nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Everolimus—kidney cancer	0.148	0.293	CbGbCtD
Salbutamol—CYP3A4—Temsirolimus—kidney cancer	0.1	0.198	CbGbCtD
Salbutamol—CYP3A4—Pazopanib—kidney cancer	0.0526	0.104	CbGbCtD
Salbutamol—CYP3A4—Erlotinib—kidney cancer	0.0375	0.0741	CbGbCtD
Salbutamol—CYP3A4—Paclitaxel—kidney cancer	0.0344	0.0678	CbGbCtD
Salbutamol—CYP3A4—Sorafenib—kidney cancer	0.0305	0.0603	CbGbCtD
Salbutamol—CYP3A4—Vinblastine—kidney cancer	0.0301	0.0595	CbGbCtD
Salbutamol—CYP3A4—Vincristine—kidney cancer	0.0296	0.0585	CbGbCtD
Salbutamol—CYP3A4—Sunitinib—kidney cancer	0.0247	0.0488	CbGbCtD
Salbutamol—CYP3A4—Doxorubicin—kidney cancer	0.0185	0.0366	CbGbCtD
Salbutamol—Isoprenaline—MAPK1—kidney cancer	0.00299	0.383	CrCbGaD
Salbutamol—Terbutaline—BCHE—kidney cancer	0.00218	0.279	CrCbGaD
Salbutamol—Clenbuterol—CYP1A1—kidney cancer	0.00129	0.165	CrCbGaD
Salbutamol—Nadolol—ABCB1—kidney cancer	0.000708	0.0907	CrCbGaD
Salbutamol—Isoprenaline—CYP1A1—kidney cancer	0.000643	0.0823	CrCbGaD
Salbutamol—Diarrhoea—Sorafenib—kidney cancer	0.000259	0.000534	CcSEcCtD
Salbutamol—Hypertension—Paclitaxel—kidney cancer	0.000259	0.000534	CcSEcCtD
Salbutamol—Pruritus—Sunitinib—kidney cancer	0.000258	0.000531	CcSEcCtD
Salbutamol—Angiopathy—Capecitabine—kidney cancer	0.000257	0.000529	CcSEcCtD
Salbutamol—Immune system disorder—Capecitabine—kidney cancer	0.000256	0.000526	CcSEcCtD
Salbutamol—Arthralgia—Paclitaxel—kidney cancer	0.000256	0.000526	CcSEcCtD
Salbutamol—Chest pain—Paclitaxel—kidney cancer	0.000256	0.000526	CcSEcCtD
Salbutamol—Myalgia—Paclitaxel—kidney cancer	0.000256	0.000526	CcSEcCtD
Salbutamol—Mediastinal disorder—Capecitabine—kidney cancer	0.000255	0.000525	CcSEcCtD
Salbutamol—Anxiety—Paclitaxel—kidney cancer	0.000255	0.000524	CcSEcCtD
Salbutamol—Decreased appetite—Gemcitabine—kidney cancer	0.000254	0.000524	CcSEcCtD
Salbutamol—Hypersensitivity—Dactinomycin—kidney cancer	0.000254	0.000524	CcSEcCtD
Salbutamol—Chills—Capecitabine—kidney cancer	0.000254	0.000523	CcSEcCtD
Salbutamol—Arrhythmia—Capecitabine—kidney cancer	0.000253	0.00052	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000253	0.00052	CcSEcCtD
Salbutamol—Discomfort—Paclitaxel—kidney cancer	0.000252	0.00052	CcSEcCtD
Salbutamol—Fatigue—Gemcitabine—kidney cancer	0.000252	0.000519	CcSEcCtD
Salbutamol—Gastrointestinal pain—Vincristine—kidney cancer	0.000252	0.000519	CcSEcCtD
Salbutamol—Dizziness—Sorafenib—kidney cancer	0.000251	0.000516	CcSEcCtD
Salbutamol—Constipation—Gemcitabine—kidney cancer	0.00025	0.000515	CcSEcCtD
Salbutamol—Pain—Gemcitabine—kidney cancer	0.00025	0.000515	CcSEcCtD
Salbutamol—Nausea—Erlotinib—kidney cancer	0.00025	0.000515	CcSEcCtD
Salbutamol—Dry mouth—Paclitaxel—kidney cancer	0.00025	0.000515	CcSEcCtD
Salbutamol—Mood swings—Doxorubicin—kidney cancer	0.00025	0.000514	CcSEcCtD
Salbutamol—Diarrhoea—Sunitinib—kidney cancer	0.000249	0.000514	CcSEcCtD
Salbutamol—Ataxia—Doxorubicin—kidney cancer	0.000248	0.00051	CcSEcCtD
Salbutamol—Mental disorder—Capecitabine—kidney cancer	0.000248	0.00051	CcSEcCtD
Salbutamol—Asthenia—Dactinomycin—kidney cancer	0.000248	0.00051	CcSEcCtD
Salbutamol—Malnutrition—Capecitabine—kidney cancer	0.000246	0.000507	CcSEcCtD
Salbutamol—Anaphylactic shock—Paclitaxel—kidney cancer	0.000245	0.000504	CcSEcCtD
Salbutamol—Oedema—Paclitaxel—kidney cancer	0.000245	0.000504	CcSEcCtD
Salbutamol—Abdominal pain—Vincristine—kidney cancer	0.000244	0.000502	CcSEcCtD
Salbutamol—Body temperature increased—Vincristine—kidney cancer	0.000244	0.000502	CcSEcCtD
Salbutamol—Infection—Paclitaxel—kidney cancer	0.000243	0.000501	CcSEcCtD
Salbutamol—Flatulence—Capecitabine—kidney cancer	0.000243	0.0005	CcSEcCtD
Salbutamol—Dysgeusia—Capecitabine—kidney cancer	0.000241	0.000497	CcSEcCtD
Salbutamol—Dizziness—Sunitinib—kidney cancer	0.000241	0.000496	CcSEcCtD
Salbutamol—Feeling abnormal—Gemcitabine—kidney cancer	0.000241	0.000496	CcSEcCtD
Salbutamol—Shock—Paclitaxel—kidney cancer	0.000241	0.000496	CcSEcCtD
Salbutamol—Vomiting—Sorafenib—kidney cancer	0.000241	0.000496	CcSEcCtD
Salbutamol—Abdominal pain upper—Doxorubicin—kidney cancer	0.000241	0.000496	CcSEcCtD
Salbutamol—Nervous system disorder—Paclitaxel—kidney cancer	0.00024	0.000495	CcSEcCtD
Salbutamol—Hypokalaemia—Doxorubicin—kidney cancer	0.00024	0.000494	CcSEcCtD
Salbutamol—Tachycardia—Paclitaxel—kidney cancer	0.000239	0.000492	CcSEcCtD
Salbutamol—Rash—Sorafenib—kidney cancer	0.000239	0.000492	CcSEcCtD
Salbutamol—Dermatitis—Sorafenib—kidney cancer	0.000239	0.000491	CcSEcCtD
Salbutamol—Back pain—Capecitabine—kidney cancer	0.000238	0.000491	CcSEcCtD
Salbutamol—Skin disorder—Paclitaxel—kidney cancer	0.000238	0.00049	CcSEcCtD
Salbutamol—Headache—Sorafenib—kidney cancer	0.000237	0.000489	CcSEcCtD
Salbutamol—Muscle spasms—Capecitabine—kidney cancer	0.000237	0.000488	CcSEcCtD
Salbutamol—Hyperhidrosis—Paclitaxel—kidney cancer	0.000237	0.000488	CcSEcCtD
Salbutamol—Diarrhoea—Dactinomycin—kidney cancer	0.000236	0.000486	CcSEcCtD
Salbutamol—Nasopharyngitis—Doxorubicin—kidney cancer	0.000236	0.000485	CcSEcCtD
Salbutamol—Anorexia—Paclitaxel—kidney cancer	0.000233	0.000481	CcSEcCtD
Salbutamol—Vomiting—Sunitinib—kidney cancer	0.000232	0.000477	CcSEcCtD
Salbutamol—Body temperature increased—Gemcitabine—kidney cancer	0.000231	0.000476	CcSEcCtD
Salbutamol—Tremor—Capecitabine—kidney cancer	0.000231	0.000475	CcSEcCtD
Salbutamol—Rash—Sunitinib—kidney cancer	0.00023	0.000473	CcSEcCtD
Salbutamol—Dermatitis—Sunitinib—kidney cancer	0.00023	0.000473	CcSEcCtD
Salbutamol—Abdominal distension—Doxorubicin—kidney cancer	0.000229	0.000472	CcSEcCtD
Salbutamol—Hypotension—Paclitaxel—kidney cancer	0.000229	0.000471	CcSEcCtD
Salbutamol—Ill-defined disorder—Capecitabine—kidney cancer	0.000229	0.000471	CcSEcCtD
Salbutamol—Headache—Sunitinib—kidney cancer	0.000228	0.00047	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—kidney cancer	0.000228	0.000469	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—kidney cancer	0.000228	0.000469	CcSEcCtD
Salbutamol—Hypersensitivity—Vincristine—kidney cancer	0.000227	0.000468	CcSEcCtD
Salbutamol—Nausea—Sorafenib—kidney cancer	0.000225	0.000463	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000223	0.00046	CcSEcCtD
Salbutamol—Malaise—Capecitabine—kidney cancer	0.000222	0.000457	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—kidney cancer	0.000222	0.000457	CcSEcCtD
Salbutamol—Insomnia—Paclitaxel—kidney cancer	0.000222	0.000456	CcSEcCtD
Salbutamol—Vertigo—Capecitabine—kidney cancer	0.000221	0.000456	CcSEcCtD
Salbutamol—Asthenia—Vincristine—kidney cancer	0.000221	0.000456	CcSEcCtD
Salbutamol—Syncope—Capecitabine—kidney cancer	0.000221	0.000455	CcSEcCtD
Salbutamol—Paraesthesia—Paclitaxel—kidney cancer	0.00022	0.000453	CcSEcCtD
Salbutamol—Vomiting—Dactinomycin—kidney cancer	0.000219	0.000452	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—kidney cancer	0.000219	0.000451	CcSEcCtD
Salbutamol—Dyspnoea—Paclitaxel—kidney cancer	0.000218	0.00045	CcSEcCtD
Salbutamol—Somnolence—Paclitaxel—kidney cancer	0.000218	0.000448	CcSEcCtD
Salbutamol—Palpitations—Capecitabine—kidney cancer	0.000218	0.000448	CcSEcCtD
Salbutamol—Rash—Dactinomycin—kidney cancer	0.000218	0.000448	CcSEcCtD
Salbutamol—Nausea—Sunitinib—kidney cancer	0.000217	0.000446	CcSEcCtD
Salbutamol—Loss of consciousness—Capecitabine—kidney cancer	0.000216	0.000446	CcSEcCtD
Salbutamol—Dyspepsia—Paclitaxel—kidney cancer	0.000216	0.000444	CcSEcCtD
Salbutamol—Cough—Capecitabine—kidney cancer	0.000215	0.000443	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—kidney cancer	0.000213	0.000439	CcSEcCtD
Salbutamol—Decreased appetite—Paclitaxel—kidney cancer	0.000213	0.000438	CcSEcCtD
Salbutamol—Hypertension—Capecitabine—kidney cancer	0.000213	0.000438	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000212	0.000436	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000211	0.000435	CcSEcCtD
Salbutamol—Fatigue—Paclitaxel—kidney cancer	0.000211	0.000435	CcSEcCtD
Salbutamol—Diarrhoea—Vincristine—kidney cancer	0.000211	0.000434	CcSEcCtD
Salbutamol—Asthenia—Gemcitabine—kidney cancer	0.00021	0.000432	CcSEcCtD
Salbutamol—Arthralgia—Capecitabine—kidney cancer	0.00021	0.000432	CcSEcCtD
Salbutamol—Chest pain—Capecitabine—kidney cancer	0.00021	0.000432	CcSEcCtD
Salbutamol—Myalgia—Capecitabine—kidney cancer	0.00021	0.000432	CcSEcCtD
Salbutamol—Constipation—Paclitaxel—kidney cancer	0.000209	0.000431	CcSEcCtD
Salbutamol—Pain—Paclitaxel—kidney cancer	0.000209	0.000431	CcSEcCtD
Salbutamol—Anxiety—Capecitabine—kidney cancer	0.000209	0.00043	CcSEcCtD
Salbutamol—Discomfort—Capecitabine—kidney cancer	0.000207	0.000427	CcSEcCtD
Salbutamol—Pruritus—Gemcitabine—kidney cancer	0.000207	0.000426	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—kidney cancer	0.000206	0.000423	CcSEcCtD
Salbutamol—Dry mouth—Capecitabine—kidney cancer	0.000205	0.000422	CcSEcCtD
Salbutamol—Nausea—Dactinomycin—kidney cancer	0.000205	0.000422	CcSEcCtD
Salbutamol—Dizziness—Vincristine—kidney cancer	0.000204	0.00042	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—kidney cancer	0.000203	0.000418	CcSEcCtD
Salbutamol—Feeling abnormal—Paclitaxel—kidney cancer	0.000202	0.000416	CcSEcCtD
Salbutamol—Oedema—Capecitabine—kidney cancer	0.000201	0.000414	CcSEcCtD
Salbutamol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.0002	0.000412	CcSEcCtD
Salbutamol—Diarrhoea—Gemcitabine—kidney cancer	0.0002	0.000412	CcSEcCtD
Salbutamol—Infection—Capecitabine—kidney cancer	0.0002	0.000411	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000199	0.00041	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—kidney cancer	0.000198	0.000408	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—kidney cancer	0.000198	0.000408	CcSEcCtD
Salbutamol—Shock—Capecitabine—kidney cancer	0.000198	0.000407	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—kidney cancer	0.000197	0.000407	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—kidney cancer	0.000197	0.000407	CcSEcCtD
Salbutamol—Nervous system disorder—Capecitabine—kidney cancer	0.000197	0.000406	CcSEcCtD
Salbutamol—Tachycardia—Capecitabine—kidney cancer	0.000196	0.000404	CcSEcCtD
Salbutamol—Vomiting—Vincristine—kidney cancer	0.000196	0.000404	CcSEcCtD
Salbutamol—Skin disorder—Capecitabine—kidney cancer	0.000195	0.000402	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—kidney cancer	0.000195	0.000401	CcSEcCtD
Salbutamol—Urticaria—Paclitaxel—kidney cancer	0.000195	0.000401	CcSEcCtD
Salbutamol—Rash—Vincristine—kidney cancer	0.000194	0.0004	CcSEcCtD
Salbutamol—Hyperhidrosis—Capecitabine—kidney cancer	0.000194	0.0004	CcSEcCtD
Salbutamol—Dermatitis—Vincristine—kidney cancer	0.000194	0.0004	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—kidney cancer	0.000194	0.000399	CcSEcCtD
Salbutamol—Abdominal pain—Paclitaxel—kidney cancer	0.000194	0.000399	CcSEcCtD
Salbutamol—Body temperature increased—Paclitaxel—kidney cancer	0.000194	0.000399	CcSEcCtD
Salbutamol—Headache—Vincristine—kidney cancer	0.000193	0.000398	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—kidney cancer	0.000192	0.000395	CcSEcCtD
Salbutamol—Anorexia—Capecitabine—kidney cancer	0.000192	0.000395	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—kidney cancer	0.000191	0.000392	CcSEcCtD
Salbutamol—Hypotension—Capecitabine—kidney cancer	0.000188	0.000387	CcSEcCtD
Salbutamol—Vomiting—Gemcitabine—kidney cancer	0.000186	0.000383	CcSEcCtD
Salbutamol—Rash—Gemcitabine—kidney cancer	0.000184	0.00038	CcSEcCtD
Salbutamol—Dermatitis—Gemcitabine—kidney cancer	0.000184	0.000379	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—kidney cancer	0.000183	0.000377	CcSEcCtD
Salbutamol—Headache—Gemcitabine—kidney cancer	0.000183	0.000377	CcSEcCtD
Salbutamol—Nausea—Vincristine—kidney cancer	0.000183	0.000377	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000183	0.000377	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—kidney cancer	0.000183	0.000376	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—kidney cancer	0.000182	0.000376	CcSEcCtD
Salbutamol—Insomnia—Capecitabine—kidney cancer	0.000182	0.000374	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—kidney cancer	0.000181	0.000374	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—kidney cancer	0.000181	0.000373	CcSEcCtD
Salbutamol—Paraesthesia—Capecitabine—kidney cancer	0.000181	0.000372	CcSEcCtD
Salbutamol—Hypersensitivity—Paclitaxel—kidney cancer	0.00018	0.000372	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—kidney cancer	0.00018	0.000371	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—kidney cancer	0.000179	0.000369	CcSEcCtD
Salbutamol—Dyspnoea—Capecitabine—kidney cancer	0.000179	0.000369	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—kidney cancer	0.000179	0.000368	CcSEcCtD
Salbutamol—Dyspepsia—Capecitabine—kidney cancer	0.000177	0.000364	CcSEcCtD
Salbutamol—Asthenia—Paclitaxel—kidney cancer	0.000176	0.000362	CcSEcCtD
Salbutamol—Decreased appetite—Capecitabine—kidney cancer	0.000175	0.00036	CcSEcCtD
Salbutamol—Nausea—Gemcitabine—kidney cancer	0.000174	0.000358	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000174	0.000357	CcSEcCtD
Salbutamol—Fatigue—Capecitabine—kidney cancer	0.000173	0.000357	CcSEcCtD
Salbutamol—Pruritus—Paclitaxel—kidney cancer	0.000173	0.000357	CcSEcCtD
Salbutamol—Constipation—Capecitabine—kidney cancer	0.000172	0.000354	CcSEcCtD
Salbutamol—Pain—Capecitabine—kidney cancer	0.000172	0.000354	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—kidney cancer	0.00017	0.00035	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—kidney cancer	0.000169	0.000349	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—kidney cancer	0.000169	0.000349	CcSEcCtD
Salbutamol—Diarrhoea—Paclitaxel—kidney cancer	0.000168	0.000345	CcSEcCtD
Salbutamol—Feeling abnormal—Capecitabine—kidney cancer	0.000166	0.000341	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—kidney cancer	0.000165	0.000341	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—kidney cancer	0.000165	0.000339	CcSEcCtD
Salbutamol—Gastrointestinal pain—Capecitabine—kidney cancer	0.000164	0.000338	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—kidney cancer	0.000164	0.000338	CcSEcCtD
Salbutamol—Chills—Doxorubicin—kidney cancer	0.000164	0.000337	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—kidney cancer	0.000163	0.000335	CcSEcCtD
Salbutamol—Dizziness—Paclitaxel—kidney cancer	0.000162	0.000334	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—kidney cancer	0.00016	0.000329	CcSEcCtD
Salbutamol—Urticaria—Capecitabine—kidney cancer	0.00016	0.000329	CcSEcCtD
Salbutamol—Body temperature increased—Capecitabine—kidney cancer	0.000159	0.000327	CcSEcCtD
Salbutamol—Abdominal pain—Capecitabine—kidney cancer	0.000159	0.000327	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—kidney cancer	0.000159	0.000327	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—kidney cancer	0.000156	0.000322	CcSEcCtD
Salbutamol—Tension—Doxorubicin—kidney cancer	0.000156	0.000321	CcSEcCtD
Salbutamol—Vomiting—Paclitaxel—kidney cancer	0.000156	0.000321	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—kidney cancer	0.000155	0.00032	CcSEcCtD
Salbutamol—Rash—Paclitaxel—kidney cancer	0.000154	0.000318	CcSEcCtD
Salbutamol—Dermatitis—Paclitaxel—kidney cancer	0.000154	0.000318	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—kidney cancer	0.000154	0.000318	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—kidney cancer	0.000154	0.000316	CcSEcCtD
Salbutamol—Headache—Paclitaxel—kidney cancer	0.000153	0.000316	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—kidney cancer	0.000153	0.000314	CcSEcCtD
Salbutamol—Hypersensitivity—Capecitabine—kidney cancer	0.000148	0.000305	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—kidney cancer	0.000147	0.000303	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—kidney cancer	0.000146	0.0003	CcSEcCtD
Salbutamol—Nausea—Paclitaxel—kidney cancer	0.000146	0.0003	CcSEcCtD
Salbutamol—Asthenia—Capecitabine—kidney cancer	0.000144	0.000297	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—kidney cancer	0.000143	0.000295	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—kidney cancer	0.000143	0.000294	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—kidney cancer	0.000142	0.000293	CcSEcCtD
Salbutamol—Pruritus—Capecitabine—kidney cancer	0.000142	0.000293	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—kidney cancer	0.00014	0.000289	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—kidney cancer	0.00014	0.000287	CcSEcCtD
Salbutamol—Cough—Doxorubicin—kidney cancer	0.000139	0.000285	CcSEcCtD
Salbutamol—Diarrhoea—Capecitabine—kidney cancer	0.000138	0.000283	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—kidney cancer	0.000137	0.000282	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—kidney cancer	0.000135	0.000278	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—kidney cancer	0.000135	0.000278	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—kidney cancer	0.000135	0.000278	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—kidney cancer	0.000135	0.000277	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—kidney cancer	0.000134	0.000275	CcSEcCtD
Salbutamol—Dizziness—Capecitabine—kidney cancer	0.000133	0.000274	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—kidney cancer	0.000132	0.000272	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—kidney cancer	0.00013	0.000267	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—kidney cancer	0.00013	0.000267	CcSEcCtD
Salbutamol—Infection—Doxorubicin—kidney cancer	0.000129	0.000265	CcSEcCtD
Salbutamol—Vomiting—Capecitabine—kidney cancer	0.000128	0.000263	CcSEcCtD
Salbutamol—Shock—Doxorubicin—kidney cancer	0.000127	0.000262	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—kidney cancer	0.000127	0.000262	CcSEcCtD
Salbutamol—Rash—Capecitabine—kidney cancer	0.000127	0.000261	CcSEcCtD
Salbutamol—Dermatitis—Capecitabine—kidney cancer	0.000127	0.000261	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—kidney cancer	0.000126	0.00026	CcSEcCtD
Salbutamol—Headache—Capecitabine—kidney cancer	0.000126	0.000259	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—kidney cancer	0.000126	0.000259	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—kidney cancer	0.000125	0.000258	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—kidney cancer	0.000124	0.000254	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—kidney cancer	0.000121	0.000249	CcSEcCtD
Salbutamol—Nausea—Capecitabine—kidney cancer	0.000119	0.000246	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000118	0.000243	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—kidney cancer	0.000117	0.000241	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—kidney cancer	0.000116	0.00024	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—kidney cancer	0.000116	0.000238	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—kidney cancer	0.000115	0.000237	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—kidney cancer	0.000114	0.000235	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—kidney cancer	0.000113	0.000232	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000112	0.00023	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—kidney cancer	0.000112	0.00023	CcSEcCtD
Salbutamol—Pain—Doxorubicin—kidney cancer	0.000111	0.000228	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—kidney cancer	0.000111	0.000228	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—kidney cancer	0.000107	0.00022	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000106	0.000218	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—kidney cancer	0.000103	0.000212	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—kidney cancer	0.000102	0.000211	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—kidney cancer	0.000102	0.000211	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—kidney cancer	9.55e-05	0.000197	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—kidney cancer	9.3e-05	0.000191	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—kidney cancer	9.17e-05	0.000189	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—kidney cancer	8.87e-05	0.000183	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—kidney cancer	8.57e-05	0.000176	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—kidney cancer	8.24e-05	0.00017	CcSEcCtD
Salbutamol—Rash—Doxorubicin—kidney cancer	8.17e-05	0.000168	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—kidney cancer	8.16e-05	0.000168	CcSEcCtD
Salbutamol—Headache—Doxorubicin—kidney cancer	8.12e-05	0.000167	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—kidney cancer	7.7e-05	0.000158	CcSEcCtD
